Gilteritinib or chemotherapy for relapsed or refractory FLT3-mutated AML

Alexander E. Perl, Giovanni Martinelli, Jorge E. Cortes, Andreas Neubauer, Ellin Berman, Stefania Paolini, Pau Montesinos, Maria R. Baer, Richard A. Larson, Celalettin Ustun, Francesco Fabbiano, Harry P. Erba, Antonio Di Stasi, Robert Stuart, Rebecca Olin, Margaret Kasner, Fabio Ciceri, Wen Chien Chou, Nikolai Podoltsev, Christian RecherHisayuki Yokoyama, Naoko Hosono, Sung Soo Yoon, Je Hwan Lee, Timothy Pardee, Amir T. Fathi, Chaofeng Liu, Nahla Hasabou, Xuan Liu, Erkut Bahceci, Mark J. Levis

Research output: Contribution to journal › Article › peer-review

756 Scopus citations

Fingerprint

Dive into the research topics of 'Gilteritinib or chemotherapy for relapsed or refractory FLT3-mutated AML'. Together they form a unique fingerprint.

Medicine & Life Sciences